Literature DB >> 581443

[Endocervical form of the vaginal adenosis (author's transl)].

K A Walz, H Metzger, H Ludwig.   

Abstract

Vaginal adenosis is a rare kind of disease without specific symptoms and does not represent a very serious disorder from the beginning. Concerning the etiology teratogenetic dependencies are known which still are interpreted in different ways in the recent literature. The increased number of cases, including those with clear-cell-carcinoma of the vagina, in juveniles after exposition to DES during the early embryonal development shows in particular (Central index for the stilbestrol-adenosis-carcinoma-syndrome in the USA, since 1971) a wrong pathway in the organogenesis of cervix and vagina. This occurs at the interference zone between the epithelium of the Müllerian ducts and the epithelium of the sinus urogenitalis of the female fetus and in so far constitutes the origin of vaginal adenosis. The basics of the possibility of the development of such irregular differentiation and heterotopic dissemination are proven again by the case report of a vaginal adenosis showing the highly differentiated endocervical type. Not every case of vaginal adenosis does signify a precancerous lesion. The separation of the most frequently endocervical manifestation observed from endometrial and intermediate forms might be difficult. A positive distinction is prognostically essential, however, since clear-cell-carcinomas of the vagina are known in occurence with the endometrial type of vaginal adenosis only. Scanning electron microscopy as a method to follow tissue organization reveals the way of differentiation between the various types via ultrastructural analysis for vaginal adenosis is an example for failures of developmental organization. The same analysis is feasible in cytological smears also. The therapeutic requirements of vaginal adenosis depend on the tissular differentiation and the given local extent of the adenomatous lesions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 581443     DOI: 10.1007/bf02570573

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


  21 in total

1.  Late effects in the vaginal and cervical epithelia after injections of diethylstilbestrol into neonatal mice.

Authors:  J G Forsberg
Journal:  Am J Obstet Gynecol       Date:  1975-01-01       Impact factor: 8.661

2.  Vaginal lesions of adenomatous origin.

Authors:  W E STUDDIFORD
Journal:  Am J Obstet Gynecol       Date:  1957-03       Impact factor: 8.661

3.  [Ectopia of the vaginal mucosa].

Authors:  V LANE; V DOHNAL
Journal:  Neoplasma       Date:  1961       Impact factor: 2.575

4.  Clear cell carcinoma of cervix and vagina in progeny of women who received diethylstilbestrol: three cases with scanning and transmission electron microscopy.

Authors:  S Puri; C M Fenoglio; R M Richart; D Townsend
Journal:  Am J Obstet Gynecol       Date:  1977-07-01       Impact factor: 8.661

Review 5.  Cervicovaginal epithelium: its origin and development.

Authors:  J G Forsberg
Journal:  Am J Obstet Gynecol       Date:  1973-04-01       Impact factor: 8.661

6.  Cervical-vaginal adenosis after in utero exposure to synthetic estrogens.

Authors:  A I Sherman; M Goldrath; A Berlin; V Vakhariya; F Banooni; W Michaels; P Goodman; S Brown
Journal:  Obstet Gynecol       Date:  1974-10       Impact factor: 7.661

7.  The incidence and distribution of occult vaginal adenosis.

Authors:  E C Sandberg
Journal:  Am J Obstet Gynecol       Date:  1968-06-01       Impact factor: 8.661

8.  Estrogen, vaginal cancer, and vaginal development.

Authors:  J G Forsberg
Journal:  Am J Obstet Gynecol       Date:  1972-05-01       Impact factor: 8.661

9.  Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas).

Authors:  A L Herbst; R E Scully
Journal:  Cancer       Date:  1970-04       Impact factor: 6.860

10.  Scanning and transmission electron microscopic studies of vaginal adenosis and the cervical transformation zone in progeny exposed in utero to diethylstilbestrol.

Authors:  C M Fenoglio; A Ferenczy; R M Richart; D Townsend
Journal:  Am J Obstet Gynecol       Date:  1976-09-15       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.